Immunity following SARS-CoV-2 vaccination in autoimmune neurological disorders treated with rituximab or ocrelizumab

Immunity following SARS-CoV-2 vaccination in autoimmune neurological disorders treated with rituximab or ocrelizumab

BackgroundRituximab (RTX) and ocrelizumab (OCR), B cell-depleting therapy targeting CD20 molecules, affect the humoral immune response after vaccination. How these therapies influence T-cell-mediated immune response against SARS-CoV-2 after immunization remains unclear. We aimed to evaluate the humo...

Full description

Bibliographic Details
Main Authors:	Petra Nytrova, Dominika Stastna, Adam Tesar, Ingrid Menkyova, Helena Posova, Helena Koprivova, Veronika Mikulova, Jiri Hrdy, Gabriela Smela, Dana Horakova, Irena Rysankova, Kristyna Doleckova, Michaela Tyblova
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-06-01
Series:	Frontiers in Immunology
Subjects:	SARS-CoV-2 mRNA vaccine SARS-CoV-2 humoral immune response IFN gamma release assay myasthenia gravis multiple sclerosis
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1149629/full

Similar Items

Cogan’s sign in a patient with suspected post-COVID-19 vaccine-associated myasthenia gravis
by: José Wagner Leonel Tavares-Júnior, et al.
Published: (2023-06-01)

Safety of inactivated SARS-CoV-2 vaccines in myasthenia gravis: A survey-based study
by: Hong-Yan Li, et al.
Published: (2022-08-01)

Comparing the Impact of COVID-19 on Vaccinated and Unvaccinated Patients Affected by Myasthenia Gravis
by: Elena Scarsi, et al.
Published: (2023-04-01)

The safety of COVID-19 vaccines in patients with myasthenia gravis: A scoping review
by: Siyang Peng, et al.
Published: (2022-12-01)

COVID-19 Vaccination in Patients with Myasthenia Gravis: A Single-Center Case Series
by: Zhe Ruan, et al.
Published: (2021-09-01)

Myasthenia Gravis and COVID-19: Clinical Characteristics and Outcomes
by: Antonio E. Camelo-Filho, et al.
Published: (2020-09-01)

Immunogenicity of repeat COVID-19 mRNA vaccinations in a patient with myasthenia gravis receiving mycophenolate, prednisone, and eculizumab
by: Lisa C. Plymate, MD, et al.
Published: (2021-01-01)

Impact of COVID-19 in AChR Myasthenia Gravis and the Safety of Vaccines: Data from an Italian Cohort
by: Antonino Lupica, et al.
Published: (2022-04-01)

COVID-19 in a Neuroimmunological Outpatient Cohort: The Bernese Experience
by: Maximilian Pistor, et al.
Published: (2022-02-01)

In Silico Design of Peptide-Based SARS-CoV-2 Fusion Inhibitors That Target WT and Mutant Versions of SARS-CoV-2 HR1 Domains
by: Shana V. Stoddard, et al.
Published: (2021-07-01)

COVID-19: a modern trigger for Guillain-Barre syndrome, myasthenia gravis, and small fiber neuropathy
by: Francisco Gomez, et al.
Published: (2023-08-01)

Promising Antiviral Activities of Natural Flavonoids against SARS-CoV-2 Targets: Systematic Review
by: Ridhima Kaul, et al.
Published: (2021-10-01)

SARS-CoV-2, the other face to SARS-CoV and MERS-CoV: Future predictions
by: T.M. Abdelghany, et al.
Published: (2021-03-01)

Chemokine Regulation During Epidemic Coronavirus Infection
by: Shamik Majumdar, et al.
Published: (2021-02-01)

Isolation of SARS-CoV-2 from the air in a car driven by a COVID patient with mild illness
by: John A. Lednicky, et al.
Published: (2021-07-01)

Potential Immunogenic Activity of Computationally Designed mRNA- and Peptide-Based Prophylactic Vaccines against MERS, SARS-CoV, and SARS-CoV-2: A Reverse Vaccinology Approach
by: Taimoor Khan, et al.
Published: (2022-04-01)

Human Coronavirus Spike Protein Based Multi-Epitope Vaccine against COVID-19 and Potential Future Zoonotic Coronaviruses by Using Immunoinformatic Approaches
by: Zulqarnain Baloch, et al.
Published: (2022-07-01)

Comparison and Analysis of Neutralizing Antibody Levels in Serum after Inoculating with SARS-CoV-2, MERS-CoV, or SARS-CoV Vaccines in Humans
by: Sicong Yu, et al.
Published: (2021-06-01)

Highly pathogenic coronaviruses: thrusting vaccine development in the spotlight
by: Chunting He, et al.
Published: (2020-07-01)

EMERGENCIA DE SARS-COV-2. ASPECTOS BÁSICOS SOBRE SU ORIGEN, EPIDEMIOLOGÍA, ESTRUCTURA Y PATOGENIA PARA CLÍNICOS
by: Jeannette Dabanch
Published: (2021-01-01)

Recent Chronology of COVID-19 Pandemic
by: Sazada Siddiqui, et al.
Published: (2022-05-01)

The interplay between emerging human coronavirus infections and autophagy
by: Zhenyu Zhao, et al.
Published: (2021-01-01)

Data mining of coronavirus: SARS-CoV-2, SARS-CoV and MERS-CoV
by: Jung Eun Huh, et al.
Published: (2021-04-01)

The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections
by: Yun-yu Zhang, et al.
Published: (2020-08-01)

SARS-CoV-2 mutations on diagnostic gene targets in the second wave in Zimbabwe: A retrospective genomic analysis
by: C Nyagupe, et al.
Published: (2023-03-01)

Mechanistic insights of host cell fusion of SARS-CoV-1 and SARS-CoV-2 from atomic resolution structure and membrane dynamics
by: Chakraborty, Hirak, et al.
Published: (2021)

Postinfectious Onset of Myasthenia Gravis in a COVID-19 Patient
by: Meret Huber, et al.
Published: (2020-10-01)

Is The SARS-CoV2 Evolved in Human Being: A prospective Genetic Analysis
by: Salvatore Dimonte, et al.
Published: (2020-12-01)

Insight into 2019 novel coronavirus — An updated interim review and lessons from SARS-CoV and MERS-CoV
by: Mingxuan Xie, et al.
Published: (2020-05-01)

Comparative transcriptome analysis of SARS-CoV-2, SARS-CoV, MERS-CoV, and HCoV-229E identifying potential IFN/ISGs targets for inhibiting virus replication
by: Yuzhuang Liu, et al.
Published: (2023-12-01)

Long-Term Health Consequences of SARS-CoV-2: Assumptions Based on SARS-CoV-1 and MERS-CoV Infections
by: Ashutosh Khaswal, et al.
Published: (2022-07-01)

SARS, MERS and COVID-19-Associated Renal Pathology
by: Hristo Popov, et al.
Published: (2022-10-01)

Coronaviruses: Is Sialic Acid a Gate to the Eye of Cytokine Storm? From the Entry to the Effects
by: Przemyslaw Wielgat, et al.
Published: (2020-08-01)

<i>Betacoronavirus</i> Genomes: How Genomic Information has been Used to Deal with Past Outbreaks and the COVID-19 Pandemic
by: Alejandro Llanes, et al.
Published: (2020-06-01)

An Overview of the Pathogenesis, Transmission, Diagnosis, and Management of Endemic Human Coronaviruses: A Reflection on the Past and Present Episodes and Possible Future Outbreaks
by: Adeoye J. Kayode, et al.
Published: (2021-08-01)

Immune Profiling of COVID-19 in Correlation with SARS and MERS
by: Bariaa A. Khalil, et al.
Published: (2022-01-01)

Honokiol Inhibits SARS-CoV-2 Replication in Cell Culture at a Post-Entry Step
by: Clarisse Salgado-Benvindo, et al.
Published: (2023-06-01)

Contribution to pathogenesis of accessory proteins of deadly human coronaviruses
by: Jesus Hurtado-Tamayo, et al.
Published: (2023-05-01)

POTENTIAL RISK OF BRAIN DAMAGE AND POOR DEVELOPMENTAL OUTCOMES IN CHILDREN PRENATALLY EXPOSED TO SARS-COV-2: A SYSTEMATIC REVIEW
by: Marcio Leyser, et al.
Published: (2021-05-01)

The biological diversity of coronaviruses: where will the new threat come from?
by: Alexandr Khaitovich, et al.
Published: (2022-05-01)